Previous 10 | Next 10 |
NEW YORK, NY / ACCESSWIRE / August 20, 2020 / Conversion Labs, Inc. (OTCQB:CVLB), a direct-to-consumer telemedicine and wellness company, has been invited to present at LD Micro 500 virtual institutional investor conference being held on September 1-4, 2020. CEO of Conversion Labs, Just...
Conversion Labs Inc (CVLB) Q2 2020 Results Conference Call August 17, 2020 01:00 PM ET Company Participants Justin Schreiber - Chief Executive Officer Juan Piñeiro - Chief Financial Officer Stefan Galluppi - Chief Operating and Technology Officer Conference Call Participa...
NEW YORK, Aug. 17, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, reported results for the second quarter and first half ended June 30, 2020. All quarterly and first half comparisons are to the same year-ago ...
LOS ANGELES, CA / ACCESSWIRE / August 5, 2020 / LD Micro today announced the initial list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online. "For the first time in ten years, we were unable to host our mid-year conference, which ...
For July, Conversion Labs ( OTCQB:CVLB -4.2% ) reported Y/Y growth of 302% revenues to $3.6M; recurring revenue ($1.2M) from re-billed subscriptions to products and services was higher 362%. More news on: Conversion Labs, Inc., Consumer stocks news, Read more ...
NEW YORK, Aug. 03, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, reported record revenues of $3.6 million in the month of July, up more than 302% versus July 2019. For July 2020, $1.2 million was attributed to ...
NEW YORK, July 29, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, will hold a conference call on Monday, August 17, 2020 at 1:00 p.m. Eastern time to discuss its results for the second quarter ended June 30, 2020....
Conversion Labs ( OTCQB:CVLB -17.1% ) expects Q2 revenues of ~$9.2M, up 114% sequentially and 241% Y/Y, primarily driven by customer acquisitions and growth in subscription revenue generated by expanding portfolio of telemedicine, online pharmacy, and wellness brands. More news on: Con...
NEW YORK, July 07, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, reported preliminary unaudited results for its second quarter ended June 30, 2020. Revenues totaled approximately $9.2 million, up 114% sequentiall...
NEW YORK, June 16, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, has appointed noted expert in internal medicine, Dr. Jeff Toll , to its medical advisory board . As an industry thought-lead...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (NASDAQ: CVLB), a leading direct-to-patient telehealth company, has been invited to present at the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference being held on February 17...
NEW YORK, Feb. 12, 2021 (GLOBE NEWSWIRE) -- Conversion Labs, Inc . (NASDAQ: CVLB), a leading direct-to-patient telehealth company, will change its name to Life MD™ on February 22, followed by the official launch of its subscription-based primary care and concierge ser...
NEW YORK, Feb. 05, 2021 (GLOBE NEWSWIRE) -- Conversion Labs, Inc . (NASDAQ: CVLB), a leading direct-to-consumer telemedicine company, has appointed Marc Benathen as chief financial officer, effective March 1. He succeeds Juan Manuel Piñeiro Dagnery, who will continu...